| Catalog No | Package | Original Price | Price | Inventory | Quantity | Operating |
|---|---|---|---|---|---|---|
| BP4404-20mg | 20mg | $96.00 | Sign in |
|
Storage conditions：Short-term storage at 2~8℃, long-term storage at -20 ~ -80℃
Phenethyl ferulate (CAS No.: 71835-85-3), as a natural ester compound, has attracted widespread attention in recent years due to its significant content and multi-target pharmacological activity in the traditional Chinese medicinal material Qianghuo. As a classic herbal medicine for treating rheumatic diseases, one of its main active ingredients is phenylethanol ferulate. This compound not only exhibits significant inhibitory effects on inflammation-related cyclooxygenase (COX) and 5-lipoxygenase (5-LOX), but also demonstrates potential multi-target regulatory capabilities in the field of neuroprotection. This paper aims to systematically review the chemical structure and physicochemical properties, plant origin and extraction methods, pharmacological activity, mechanism of action, druggability evaluation, and clinical application prospects of phenylethanol ferulic acid ester, aiming to provide a theoretical basis and research direction for subsequent basic research and drug development.
Phenylethanol ferulic acid ester is an ester compound formed by the esterification reaction of ferulic acid and phenylethanol. Its molecular formula is C18H18O4, and its molecular weight is 298.3380. Structurally, ferulate phenylethanol ester contains a ferulic acid group with a conjugated double bond and a phenylethanol group, giving it strong antioxidant activity and lipid solubility. Its LogP value is 3.7191, indicating that this compound has good lipid solubility, which is beneficial for penetrating cell membranes and the blood-brain barrier (BBB). TPSA (Topological Polarity Surface Area) is 55.7600, and moderate polarity helps with molecular distribution and absorption in the body. Low water solubility (0.0189 mg/mL) suggests limited solubility in the aqueous phase, which may affect its bioavailability. Notably, phenylethanol ferulate has excellent blood-brain barrier penetration ability, laying the foundation for its application in neurological diseases. Additionally, the hERG channel inhibition test results were negative, indicating a low risk of cardiotoxicity; The Ames mutagenic test result was 0.0, indicating low genotoxicity risk and high safety.
Phenylethanol ferulate is mainly found in the traditional Chinese medicine Qianghuo (Ligusticum wallichii). Notopterygium is a plant in the umbelliferae, and its rhizomes are rich in volatile oils and phenolic acid compounds. Phenylethanol ferulate is an important active component in Notopterygium, with its content greatly affected by plant growth environment, harvest time, and processing techniques.
Common methods for extracting phenylethanol ferulate include solvent extraction, ultrasound-assisted extraction, and liquid chromatography separation. Traditional solvent extraction mostly uses ethanol or methanol as solvents, combined with ultrasound-assisted technology, significantly improving extraction efficiency. The extract is concentrated, liquid-liquid dispensed, and purified by silica gel column chromatography to obtain a high-purity phenylethanol ferulate ester. In recent years, green extraction technologies such as supercritical CO2 extraction have also been applied to extract this compound, offering advantages such as low solvent residue and environmental friendliness.
Phenylethanol ferulate regulates inflammatory mediators and is the core of its pharmacological activity. In vitro studies showed that this compound significantly inhibited cyclooxygenase (COX) and 5-lipoxygenase (5-LOX), with IC50s of 4.35 μM and 5.75 μM, respectively. These two enzymes are key metabolic enzymes in the inflammatory response, catalyzing the synthesis of prostaglandins and leukotrienes respectively, and participating in the amplification of inflammatory signals. Through dual-target inhibition, phenylethanol ferulate can effectively reduce the generation of inflammatory mediators, alleviate inflammatory responses, and possess potential anti-rheumatic and anti-inflammatory effects.
In recent years, research on phenylethanol ferulate in the field of neuroprotection has gradually increased. This compound regulates neuronal survival, apoptosis, and oxidative stress through multiple targets, demonstrating good neuroprotective potential. Related targets include BCL2 family proteins (regulating apoptosis), APP and BACE1 (Alzheimer's-related proteins), MAP (tubule-associated protein tau), NFE2L2 (antioxidant stress transcription factor), SIRT1 (deacetylase), MAPK1 (signal transduction protein), ACE (acetylcholinesterase), CASP3 (caspase-3), and SNCA (α-synuclein). By modulating these key molecules, phenylethanol ferulate can reduce oxidative damage to nerve cells, inhibit abnormal protein accumulation and inflammatory responses, and slow the progression of neurodegenerative diseases.
Phenylethanol ferulate has significant antioxidant properties, capable of scavenging free radicals and reducing cell damage caused by oxidative stress. By activating the NFE2L2 signaling pathway, it enhances the expression of intracellular antioxidant enzymes, enhancing the cell's antioxidant defense capabilities. At the same time, by regulating the BCL2/BAX ratio, CASP3 activity is inhibited, neuronal apoptosis is reduced, and neuroprotective effects are further exerted.
The mechanisms of action of phenylethanol ferulate are complex and diverse, involving multiple biological processes such as inflammation suppression, antioxidant activity, and neuroprotection.
By directly inhibiting COX and 5-LOX, phenylethanol ferulate reduces the synthesis of prostaglandins and leukotrienes, blocking the transmission of inflammatory signals. Additionally, this compound can inhibit activation of the NF-κB signaling pathway, reduce the expression of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, and alleviate inflammatory responses.
Phenylethanol ferulate regulates the survival and function of nerve cells through multiple targets. It activates the NFE2L2/ARE antioxidant pathway, enhancing cellular resistance to oxidative stress; Regulates SIRT1 activity, promotes cellular energy metabolism, and delays aging; Inhibits BACE1 activity, reduces β-amyloid protein production, and delays pathological progression of Alzheimer's disease; Regulating the phosphorylation state of MAPT to prevent abnormal tau protein aggregation; At the same time, it regulates CASP3-mediated apoptosis pathways to protect neurons from apoptosis damage.
Phenylethanol ferulate also affects ACE activity, regulates acetylcholine metabolism, and improves nerve conduction function; By regulating SNCA expression and reducing abnormal aggregation of α-synuclein proteins, it may have a protective effect against neurodegenerative diseases such as Parkinson's disease.
Phenylethanol ferulate demonstrates many advantages in druggability. Its molecular weight of 298.3380 complies with the Lipinski rule, with a LogP of 3.7191, indicating good lipid solubility, which is beneficial for oral absorption and cell membrane penetration. TPSA is 55.76, suitable for blood-brain barrier penetration, and experimental data confirm its high brain tissue distribution capacity. Its low water solubility may limit its bioavailability, but formulation optimization (such as nanocarriers, liposomes, etc.) can improve its leaching and absorption performance.
In terms of safety, phenylethanol ferulate does not inhibit hERG channels, reducing the risk of cardiotoxicity; A negative Ames test indicates a low genotoxicity risk and good safety. In vivo pharmacokinetic research is still in its early stages. Data already show that its plasma concentration can reach effective levels after oral administration, with a moderate half-life and a certain degree of in vivo stability.
Based on the multi-target anti-inflammatory and neuroprotective effects of phenylethanol ferulate esters, it holds great potential for application in rheumatic diseases, neurodegenerative diseases (such as Alzheimer's and Parkinson's), and cerebrovascular diseases. Currently, although most studies are still at the in vitro and animal model stages, their good druggability and safety lay the foundation for clinical translation.
Future research should focus on the following directions: First, systematically evaluate the efficacy and mechanisms of phenylethanol ferulate in different neurological disease models; Second, optimize formulation technology to improve bioavailability and targeting; Third, conduct preclinical toxicology and pharmacokinetic studies to provide data support for clinical trials; Fourth, explore its synergistic effects with existing drugs to expand its potential for compound applications.
Furthermore, by utilizing modern drug design techniques such as computer-aided drug design (CADD), structural biology, and multi-omics techniques, in-depth analysis of the interaction mechanisms between phenylethanol ferulate and its targets will help guide structural optimization and new drug development.
Phenylethanol ferulate esters, as an important active ingredient in Notchophylla, demonstrates broad drug development potential due to its remarkable anti-inflammatory and neuroprotective properties. Its multi-target mechanism of action and good druggability provide scientific evidence for its application in neurodegenerative and inflammation-related diseases. In the future, by combining modern pharmacology and medicinal chemistry, systematic research on phenylethanol ferulate will be further promoted for clinical application, benefiting a wide range of patients.
